Kohmann Bosshard Financial Services, LLC Bristol Myers Squibb CO Transaction History

Kohmann Bosshard Financial Services, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $192,223 - $227,619	2,807 New	2,807 $0
Q2 2022 Jul 08, 2022	BUY	$72.62 - $79.98 $196,582 - $216,505	2,707 New	2,707 $208,000
Q4 2021 Jan 12, 2022	SELL	$53.63 - $62.52 $187,865 - $219,007	-3,503 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $59 - $69	1 Added 0.03%	3,503 $207,000
Q2 2021 Jul 13, 2021	SELL	$61.91 - $67.42 $9,781 - $10,652	-158 Reduced 4.32%	3,502 $234,000
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $9,553 - $10,745	161 Added 4.6%	3,660 $231,000
Q4 2020 Jan 21, 2021	SELL	$57.74 - $65.43 $144,119 - $163,313	-2,496 Reduced 41.63%	3,499 $217,000
Q3 2020 Jan 07, 2021	BUY	$57.43 - $63.64 $172,232 - $190,856	2,999 Added 100.1%	5,995 $361,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $54 - $64	1 Added 0.03%	2,996 $177,000
Q1 2020 Apr 07, 2020	SELL	$46.4 - $67.43 $112,241 - $163,113	-2,419 Reduced 44.68%	2,995 $167,000
Q4 2019 Jan 09, 2020	BUY	$49.21 - $64.19 $266,422 - $347,524	5,414 New	5,414 $348,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kohmann Bosshard Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kohmann Bosshard Financial Services, LLC with notifications on news.